Tuesday
Optimising Symptoms of Fatigue, Pain and Urgency for our patients: IBD-BOOST Optimise

Hall 5
10:35-10:55


S1P Receptor Modulators: From Clinical Trials to Clinical Practice

PP-UNP-GBR-9220 May 2024

Hall 8
13:30-14:10

Gut Feelings: What could be achieved in Ulcerative Colitis?

This symposium has been developed, funded and organised by Lilly. Lilly products will be discussed at this meeting. Intended for UK healthcare professionals only
PP-MR-GB-0313 May 2024

Hall 5
16:05-16:25

The role of endoscopic techniques in the management of advanced biliary tract cancer in the era of immunotherapy

 This is an AstraZeneca sponsored promotional symposium at which AstraZeneca products will be discussed. This meeting is intended for UK healthcare professionals only

Hall 8
16:05-16:25

WEdnesday

DOAC-reversal and the management of life-threatening GI bleeds

 This is an AstraZeneca sponsored promotional symposium at which AstraZeneca products will be discussed. This meeting is intended for UK healthcare professionals only

Hall 5
08:15-08:45

Liver Disease – Role Of Aetiology, Rise Of Metabolic Disease and Its Impact

This non promotional symposium is sponsored by Eisai for UK healthcare professionals only.

UK-NON-24-00164 May 2024

Hall 8
08:15-08:45

An efficient and cost-effective approach to identify patients most at risk of Gastric Carcinogenesis

Hall 5
10:35-10:55

Long-term impact on clinical and safety outcomes in IBD

This promotional symposium is open to GB and
NI Healthcare Professionals only and has been
funded by Celltrion Healthcare UK Ltd. Celltrion
products will be discussed at this meeting.

UK-REMS-24-00032 May 2024

Hall 5
13:00-13:40

Clinical Reflections On The Use Of JAK Inhibitors And Corticosteroids: A Case Study – Insights Into Clinical Experience And Data With An Endocrinologist’s Perspective On Iatrogenic Adrenal Insufficiency

PP-UNP-GBR-9220 May 2024

Hall 8
13:00-13:40

Brightening the path in UC: Putting theory into practice

This symposium has been developed, funded and organised by Lilly. Lilly products will be discussed at this meeting. Intended for UK healthcare professionals only
PP-MR-GB-0313 Jun 2024

Hall 5
15:45-16:15


C. difficile management in IBD, who is at risk?

Hall 8
15:45-16:15

Thursday

High quality bowel cleansing: service setups for success

Hall 5
12:40-13:20